Germany

BMI believes there is significant global growth potential for third party active pharmaceutical ingredient (API) inspection firms over the next few years. This is in light of the... 2008-06-12

Switzerland-based drugmaker Nycomed is planning to sell part of its oncology pipeline to German firm 4SC in order to focus on developing drugs in its current areas of speciality.... 2008-06-06

Pharmaceutical wholesaler Phoenix Pharma France is to acquire fellow French player CERP Lorraine Répartition. The terms of the deal have not been

Germany's main regulatory body, the Federal Institute for Drugs and Medical Devices (BfArM), has controversially approved a generic form of global blockbuster Plavix (clopidogrel).... 2008-05-30

Swiss drugmaker Novartis has obtained EU approval for its multiple sclerosis (MS) treatment Extavia (interferon beta-1b), which will result in a head-to-head battle with Bayer's identical... 2008-05-29

German regional health insurer AOK Baden-Württemberg is to implement full-scale IT system integration into the primary care setting, after signing a direct primary care contract... 2008-05-27

Danish drugmaker Lundbeck has launched its new insomnia treatment Circadin (sustained release melatonin) in Germany, with 14 further European markets to follow over the course of... 2008-05-19

Highlighting the legal minefield of bioprospecting, Germany's Schwabe Pharmaceuticals is facing a challenge to two European Patent Office (EPO) patents for its phytopharmaceutical... 2008-05-14

Indian company Dabur India has sold its pharmaceutical division to German healthcare firm Fresenius Kabi. The asset mainly sells generic anticancer agents, and the purchase price... 2008-04-21

Germany's Federal Joint Committee on Healthcare (G-BA) has confirmed that it will not reimburse Plavix (clopidogrel) as a prophylactic treatment for cardiovascular disease. The decision... 2008-04-02